Jochen Gaedcke

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer.

Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 07, 2026

Repair of a thoracic incisional hernia in a patient after elective abdominothoracic esophageal resection.

Repair of a thoracic incisional hernia in a patient after elective abdominothoracic esophageal resection.

Journal: Journal of cardiothoracic surgery

Published: January 24, 2026

Impact of superior mesenteric artery (SMA) adherent tissue in the context of pancreatic head resections- an observational study.

Impact of superior mesenteric artery (SMA) adherent tissue in the context of pancreatic head resections- an observational study.

Journal: BMC cancer

Published: January 05, 2026

Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer.

Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer.

Journal: United European gastroenterology journal

Published: April 04, 2025

Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer.

Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer.

Journal: Gut

Published: November 18, 2024

Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial.

Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial.

Journal: Scientific reports

Published: October 09, 2024

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

Journal: bioRxiv : the preprint server for biology

Published: June 21, 2024

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

Journal: Carcinogenesis

Published: March 14, 2024

Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection.

Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection.

Journal: Biomedicines

Published: December 13, 2023

Short- and Long-Term Outcomes of Patients with Postoperative Arrhythmia after Liver Surgery.

Short- and Long-Term Outcomes of Patients with Postoperative Arrhythmia after Liver Surgery.

Journal: Biomedicines

Published: December 09, 2023

LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.

LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.

Journal: Carcinogenesis

Published: November 14, 2023

KRASG 12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening.

KRASG 12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening.

Journal: Molecular oncology

Published: November 03, 2023

Showing 1-12 of 109

Last Updated: 09/26/2026